medical progress Trans Fatty Acids and Cardiovascular Disease

@inproceedings{Mozaffarian2006medicalPT,
  title={medical progress Trans Fatty Acids and Cardiovascular Disease},
  author={Dariush Mozaffarian and Martijn Bernard Katan and Alberto A Ascherio and Meir Jonathan Stampfer and Walter C. Willett},
  year={2006}
}
From the Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, and the Departments of Nutrition and Epidemiology, Harvard School of Public Health — all in Boston (D.M., A.A., M.J.S., W.C.W.); and the Division of Human Nutrition, Wageningen University, and Wageningen Center for Food Sciences — both in Wageningen, the Netherlands (M.B.K.). Address reprint requests to Dr. Mozaffarian at the Harvard School of Public Health, 665 Huntington Ave., Bldg… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 72 references

Labelling of trans fatty acid content in food , regulations , and what limits pros et cons — the Danish view

  • HG Jensen
  • First International Symposium on Trans Fatty…
  • 2005

Lightly hydrogenated soy oil versus other vegetable 5 . 6 . 7 . 8 . oils as a lipidlowering dietary constitu

  • DC Laine, CM Snodgrass, EA Dawson, MA Ener, K Kuba, ID Frantz
  • Am J Clin Nutr
  • 2005

Similar Papers

Loading similar papers…